ENCBS799ICU / cell line
Summary
- Status
- released
- Term name
- SK-N-SH
- Term ID
- EFO:0003072
- Summary
- Homo sapiens SK-N-SH cell line treated with 6 μM all-trans-retinoic acid for 48 hours
- Description
- neuroblastoma cell line, treatment: differentiated with retinoic acid, (Biedler, et al. Morphology and Growth, Tumorigenicity, and Cytogenetics of Human Neuroblastoma Cells in Continuous Culture. Cancer Research 33, 2643-2652, November 1973.)
- Product ID
- HTB-11
Attribution
ENCODE2 project
- Lab
- John Stamatoyannopoulos, UW
- Award PI
- John Stamatoyannopoulos, UW
- Submitted by
- Richard Sandstrom
- Source
- ATCC
- Project
- ENCODE
- External resources
- Aliases
- john-stamatoyannopoulos:DS8476
Treatment details
- Treatment
- 6 μM all-trans-retinoic acid (CHEBI:15367) for 48 hours
- Type
- chemical
Donor information
- Status
- released
- Accession
- ENCDO000ABD
- Aliases
- encode:donor of SK-N-SH, bradley-bernstein:Donor of SK-N-SH cells, encode:donor of SH-SY5Y
- Species
- Homo sapiens
- Life stage
- child
- Age
- 4 years
- Sex
- female
- Health status
- Metastatic neuroblastoma from bone marrow
- External resources
- References
Documents
growth protocol
Description: UW ENCODE Project - Cell Culture SOPs (15 total cell lines)
- Submitted by
- John Stamatoyannopoulos
- Lab
- John Stamatoyannopoulos, UW
- Grant
- U54HG004592